Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 31, 2018 - Issue 3
67
Views
6
CrossRef citations to date
0
Altmetric
Case Studies

Anabolic androgenic steroid–induced acute myocardial infarction with multiorgan failure

, MD, , MD, , MD, , MD & , MD
Pages 334-336 | Received 18 Aug 2017, Accepted 08 Mar 2018, Published online: 15 May 2018

  • Shamloul RM, Aborayah AF, Hashad A, Abd-Allah F. Anabolic steroids abuse–induced cardiomyopathy and ischaemic stroke in a young male patient. BMJ Case Rep. 2014; 2014. doi:10.1136/bcr-2013-203033. PMID:24574525.
  • O'Sullivan AJ, Kennedy MC, Casey JH, Day RO, Corrigan B, Wodak AD. Anabolic–androgenic steroids: medical assessment of present, past and potential users. Med J Aust. 2000;173:323–327. PMID:11061405.
  • Thiblin I, Petersson A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol. 2005;19:27–44. doi:10.1111/j.1472-8206.2004.00298.x. PMID:15660958.
  • Melchert RB, Welder AA. Cardiovascular effects of androgenic–anabolic steroids. Med Sci Sports Exerc. 1995;27:1252–1262. doi:10.1249/00005768-199509000-00004. PMID:8531623.
  • Kuhn CM. Anabolic steroids. Recent Prog Horm Res. 2002;57:411–434. doi:10.1210/rp.57.1.411. PMID:12017555.
  • Marsh JD, Lehmann MH, Ritchie RH, Gwathmey JK, Green GE, Schiebinger RJ. Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation. 1998;98:256–261. doi:10.1161/01.CIR.98.3.256. PMID:9697826.
  • Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24:313–340. doi:10.1210/er.2003-0005. PMID:12788802.
  • Montisci M, El Mazloum R, Cecchetto G, et al. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int. 2012;217:e13–e18. doi:10.1016/j.forsciint.2011.10.032. PMID:22047750.
  • Dickerman RD, McConathy WJ, Zachariah NY. Testosterone, sex hormone–binding globulin, lipoproteins, and vascular disease risk. J Cardiovasc Risk. 1997;4:363–366. doi:10.1097/00043798-199710000-00008. PMID:9865668.
  • Winkler UH. Effects of androgens on haemostasis. Maturitas. 1996;24:147–155. doi:10.1016/S0378-5122(96)82004-4. PMID:8844628.
  • Thiblin I, Lindquist O, Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci. 2000;45:16–23. doi:10.1520/JFS14635J. PMID:10641914.
  • Bispo M, Valente A, Maldonado R, et al. Anabolic steroid–induced cardiomyopathy underlying acute liver failure in a young bodybuilder. World J Gastroenterol. 2009;15:2920–2922. doi:10.3748/wjg.15.2920. PMID:19533818.
  • Fussell KM, Awad JA, Ware LB. Case of fulminant hepatic failure due to unrecognized peripartum cardiomyopathy. Crit Care Med. 2005;33:891–893. doi:10.1097/01.CCM.0000158517.25962.8E. PMID:15818120.
  • Hoffman BJ, Pate MB, Marsh WH, Lee WM. Cardiomyopathy unrecognized as a cause of hepatic failure. J Clin Gastroenterol. 1990;12:306–309. doi:10.1097/00004836-199006000-00015. PMID:2362100.
  • Wiesen S, Reddy KR, Jeffers LJ, Schiff ER. Fulminant hepatic failure secondary to previously unrecognized cardiomyopathy. Dig Dis. 1995;13:199–204. doi:10.1159/000171502. PMID:8548983.
  • Sonmez E, Turkdogan KA, Yilmaz C, Kucukbuzcu S, Ozkan A, Sogutt O. Chronic anabolic androgenic steroid usage associated with acute coronary syndrome in bodybuilder. Turk J Emerg Med. 2016;16:35–37. doi:10.1016/j.tjem.2014.11.001. PMID:27239638.
  • Poorzand H, Jafarzadeh Esfehani R, Hosseinzadeh P, Vojdanparast M. Acute myocardial infarction in a young male wrestler: a case report. ARYA Atheroscler. 2015;11:366–369. PMID:26862345.
  • Frati P, Busardò FP, Cipolloni L, Dominicis ED, Fineschi V. Anabolic androgenic steroid (AAS) related deaths: autoptic, histopathological and toxicological findings. Curr Neuropharmacol. 2015;13:146–159. doi:10.2174/1570159X13666141210225414. PMID:26074749.
  • Unai S, Miessau J, Karbowski P, Baram M, Cavarocchi NC, Hirose H. Caution for anabolic androgenic steroid use: a case report of multiple organ dysfunction syndrome. Respir Care. 2013;58:e159–e163. doi:10.4187/respcare.02338. PMID:23611866.
  • Herlitz LC, Markowitz GS, Farris AB, et al. Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol. 2010;21:163–172. doi:10.1681/ASN.2009040450. PMID:19917783.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.